2021 ISPE Biotechnology Conference & Workshop

Access Virtual Conference

The 2021 ISPE Biotechnology Virtual Conference & Workshop will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists and international regulators to network, share insights and provide an outlook on the evolving landscape and future of Biopharmaceutical manufacturing and therapies. This year in particular the industry rallied together bring forward innovation at records and partnered in ways that were unprecedented to address not only the public health crisis brought on by the pandemic, but also to ensure patients worldwide would continue to have access to necessary therapies.

The virtual conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical and biopharmaceutical value chain to present recent innovations and trends, and openly discuss practical challenges and solutions, from a technical, logistical and regulatory perspective. The impact of evolving regulatory environment, and the need to ensure continued innovation and continuity of the supply chain in light of this crisis and assuring preparedness for future crisis will be integrated throughout the conference programme, panel discussions, and accompanying workshops. Participant Participants will have the opportunity to engage with industry leaders, regulators and peers through networking events and conference programs.

Included in the key focus topics are:

  • Vaccines Development, Manufacturing, Distribution –accelerated development and approval
  • Research and Development challenges for Cell and Gene Therapy, Data and Process Science
  • Technology Transfer and Operations Readiness, Case studies
  • Manufacturing and Quality for Cell and Gene Therapy Products and ATMP
  • Continuous Manufacturing for mABs, Technology Enablers, Rationalisation
  • Pharma 4.0 in Biotechnology, Robotics, Digitalisation and Validation


The programme also offers two interactive workshops, where the presentations of business cases and implemented projects will be discussed.


  • Initiate dialogue on theoretical and practical knowledge through case studies, presented by a workshop leader and with input from participants​
  • Participants can work on solutions in the form of conclusions, drafted with the support of workshop leaders​
  • Focus will be on the theoretical background and practical day-to-day execution​
  • Preferred areas are technical or regulatory ​

View Workshops

What to Expect

Why Attend Virtually

  • Feel like You're In-Person with a Fully Interactive Digital Experience
    Our event portal is easy to navigate and will allow you to view presentations, access PDFs of the presentations, take downloadable notes in each session, participate in polls, chat with other attendees, and participate in LIVE Q&A sessions with speakers.
    alt 1
  • Build Your Experience
    Add the sessions you want to attend with the click of a button to build your own custom agenda.
    alt 2
  • Gain Actionable Insights
    Global experts will be at your fingertips sharing their knowledge and lessons learned on advanced therapeutic medicinal products (ATMPs) including cell and gene therapies, digitalization, single-use technology, implications of ICH Q12 for biopharma, and much more.
    alt 3

Virtual Event FAQs

Who Should Attend

  • Professionals at all levels of the industry from young professionals to the most senior executives
  • Developers, Manufacturing and Engineering professionals involved in or interested in understanding the current state of biopharmaceutical production
  • Suppliers
  • Quality Assurance and Regulatory professionals
  • Process and Project Engineers
  • Regulators
  • Academia
  • Stakeholders of the Vaccination value chain

Media Partners

IPQ media partner
The Medicine Maker media partner

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2021 ISPE Biotechnology Conference

Company Type

Programme Committee

Michelangelo Canzoneri
Global Head of Digital and Data, Healthcare
Merck KGaA, Darmstadt, Germany
David Doleski
Compliance Head for Biologics Quality Operations
Vivianne J. Arencibia
Independent Consultant
Arencibia Quality Compliance Associates
Angelo Bernardis
Global Pharma Chief Technology Leader
Estelle Darnon
Expert Pharma / Process Architect
Technip Energies
Richard Denk
Senior Consultant Aseptic Processing & Containment
Liz M. Dooley, MSc.
Head of Biologics Clinical Planning & Operations, Janssen R&D
Janssen Sciences Ireland UC
Robert Dream, PE, CPIP
HDR Company LLC
David Estape, PhD
Technology Manager Biotechnology
CRB Group
Joseph C. Famulare
Vice President, Global Quality Compliance and External Relations
Genentech, A Member of the Roche Group
Philip M. Gammell
Associate Director of Engineering
Astellas Pharma Inc.
Christoph Herwig, PhD
Vienna University of Technology
Weining Hu
Associate Vice President., Global Regulatory Affairs-CMC
Antonio R. Moreira, PhD
Vice Provost, Academic Affairs
University of Maryland, Baltimore County
Placeholder Person Graphic
Gary O'Brien
Director, Business Development
DPS Group Global
Alice Redmond, PhD
Chief Strategy Officer
Phillip R. Smith, PhD
Director, Process Technology
Christian Wölbeling
Executive Industry Advisor
Thomas Zahel, PhD
Head of Innovation
Körber Pharma, Werum IT Solutions GmbH